Detailed View
GRTX - Galera Therapeutics, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
3,656,553,472
Adj EBIT (TTM)
-2,234,000
Enterprise Value
3,651,053,472
Last Price
17.60
Earnings Yield
-0.06%
Return on Capital
-36.24%
Capital
6,164,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 0 | -1,655,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | 1,992,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -1,436,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -1,135,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -1,963,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -5,466,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -5,908,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -4,209,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.